HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,679,380 | +2664.7% | 257,185 | +2106.3% | 0.12% | +2975.0% |
| Q2 2022 | $530,962 | -77.2% | 11,657 | -84.9% | 0.00% | -73.3% |
| Q1 2022 | $2,332,927 | -67.1% | 77,174 | -59.8% | 0.02% | -64.3% |
| Q4 2021 | $7,084,682 | -73.6% | 191,745 | -21.8% | 0.04% | -78.6% |
| Q3 2021 | $26,866,766 | +2778.9% | 245,269 | +2361.1% | 0.20% | +3166.7% |
| Q2 2021 | $933,217 | +45.6% | 9,966 | -94.9% | 0.01% | 0.0% |
| Q1 2021 | $641,151 | -87.7% | 196,366 | +175.1% | 0.01% | -85.4% |
| Q4 2020 | $5,220,789 | -31.6% | 71,371 | -27.3% | 0.04% | -51.8% |
| Q3 2020 | $7,631,000 | +111.2% | 98,224 | -44.7% | 0.08% | +97.7% |
| Q2 2020 | $3,613,000 | +944.2% | 177,700 | +1421.4% | 0.04% | +975.0% |
| Q1 2020 | $346,000 | +28.6% | 11,680 | +4.7% | 0.00% | +100.0% |
| Q2 2019 | $269,000 | – | 11,160 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |